Compare Medpace Holdings Inc (MEDP) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Utilities Select Sector SPDR Fund — how do they compare? Medpace Holdings Inc trades at $614.63 (market cap $16.82B), while Utilities Select Sector SPDR Fund trades at $41.33 (market cap $23.60B). The key difference: Utilities Select Sector SPDR Fund is the larger of the two by market cap, and Medpace Holdings Inc is trading nearer its 52-week high, Utilities Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medpace Holdings Inc for 14 Days and Utilities Select Sector SPDR Fund for 80 Days on average.
| MEDP | XLU | |
|---|---|---|
Market Cap | $16.82B | $23.60B |
Volume | 223,093 | 28,758,237 |
Sector | Health | — |
52-Week High | $630.19 | $47.73 |
52-Week Low | $393.42 | $39.25 |
Typical Hold Time | 14 Days | 80 Days |
Enterprise Value | $16.44B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $604.25, up 0.22% today, with a neutral technical signal and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected on October 21, 2026. Revenue grew to $2.53 billion in 2025, with a net income margin of 17.67% and robust ROE of 162.15%. Analyst consensus is a $620.44 price target, though institutional sentiment is mixed with recent CEO share sales.
Outlook remains positive given earnings momentum and projected 2026 revenue growth to $2.8 billion. Key risks include high valuation multiples and insider selling. The stock offers upside to consensus target but requires monitoring of Q3 earnings and competitive pressures in medical services.
XLU trades at $41.09, down 0.15% with mixed technical signals showing a bullish moving average trend but neutral oscillators. The ETF recently hit 52-week lows amid sector-wide pressure from rising interest rates. Support levels cluster around $40-41 while resistance sits at $41-42. Recent news highlights utility stocks as oversold with potential defensive appeal during market volatility.
The outlook remains cautious given interest rate sensitivity, though current levels may offer value for defensive positioning. Key risks include further rate hikes and AI power demand uncertainty. Analyst sentiment is divided with technical indicators suggesting near-term consolidation potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Utilities Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: electric utilities; water utilities; multi-utilities; independent power and renewable electricity producers; and gas utilities. The fund is non-diversified.
Read more on XLU →
